MGTX Competitors & Alternatives
Compare MeiraGTx Holdings PLC with similar stocks in the same industry
Biotechnology
MGTX
Main Stock$13.92
Tradestie Score
59
Market Cap
$665.30M
Revenue Growth
-0.8%
Analyst Upside
+102.9%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$38.97
|
$1.32B | - | 61 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$8.28
|
$1.29B | 114.3 | 58 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$32.70
|
$1.29B | - | 61 | Compare |
|
ARDX
Ardelyx, Inc.
|
$5.27
|
$1.29B | - | 49 | Compare |
|
ZYME
Zymeworks Inc.
|
$26.31
|
$1.28B | - | 53 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$5.70
|
$1.27B | - | 52 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$43.99
|
$1.26B | - | 55 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 58 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$5.19
|
$1.22B | - | 57 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$5.64
|
$1.18B | - | 58 | Compare |
More MGTX Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry